According to the Center for Information and Study on Clinical Research Participation (CISCRP), traveling to a clinical study is the top reason trial participation is disruptive for patients. Learn more about the complexities of patient travel in clinical trials and what the industry is doing about it with Chris Benevides, Director of Patient Travel Services at Elligo Health Research®. Chris offers valuable insights on early planning, risk mitigation, and specialized travel services that can s...